Dendritic cells and their role in cardiovascular diseases: A view on human studies

Journal of Immunology Research

Volumn 2016, Issue , 2016, Pages

  Dieterlen, Maja Theresa ^a   John, Katja ^a   Reichenspurner, Hermann ^b   Mohr, Friedrich W ^a   Barten, Markus J ^b  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b UNIVERSITY HEART CENTER HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN;

ATHEROSCLEROSIS; CARDIAC PATIENT; CARDIOVASCULAR DISEASE; CELL FUNCTION; CORONARY ARTERY BYPASS GRAFT; DENDRITIC CELL; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; HYPERTENSION; NONHUMAN; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW; ANTIGEN PRESENTATION; CLINICAL TRIAL (TOPIC); IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; INNATE IMMUNITY; PATHOLOGY;

ANTIGEN PRESENTATION; ANTIGENS; ATHEROSCLEROSIS; CLINICAL TRIALS AS TOPIC; CORONARY ARTERY BYPASS; DENDRITIC CELLS; HEART FAILURE; HEART TRANSPLANTATION; HUMANS; HYPERTENSION; IMMUNE TOLERANCE; IMMUNITY, INNATE;

EID: 84964801506     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2016/5946807     Document Type: Review

References (107)

1. S. Mendis, P. Puska, and B. Norrving, Global Atlas on Cardiovascular Disease Prevention and Control, WHO, Geneva, Switzerland, 2011.
2. D. A. Chistiakov, I. A. Sobenin, A. N. Orekhov, and Y. V. Bobryshev, "Myeloid dendritic cells: development, functions, and role in atherosclerotic inflammation, " Immunobiology, vol. 220, pp. 833-844, 2015.
3. A. Dzionek, A. Fuchs, P. Schmidt et al., "BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood, " The Journal of Immunology, vol. 165, no. 11, pp. 6037-6046, 2000.
4. J. Narbutt, A. Lesiak, M. Zak-Prelich et al., "The distribution of peripheral blood dendritic cells assayed by a new panel of anti- BDCA monoclonal antibodies in healthy representatives of the Polish population, " Cellular and Molecular Biology Letters, vol. 9, no. 3, pp. 497-509, 2004.
5. H. Yokoyama, S. Kuwao, K. Kohno, K. Suzuki, T. Kameya, and T. Izumi, "Cardiac dendritic cells and acute myocarditis in the human heart, " Japanese Circulation Journal, vol. 64, no. 1, pp. 57-64, 2000.
6. D. N. J. Hart and J. W. Fabre, "Demonstration and characterization of Ia-positive dendritic cells in the interstitial connective tissue of rat heart and other tissues, but not brain, " The Journal of Experimental Medicine, vol. 154, no. 2, pp. 347-361, 1981.
7. J. Zhang, Z.-X. Yu, S. Fujita, M. L. Yamaguchi, and V. J. Ferrans, "Interstitial dendritic cells of the rat heart. Quantitative and ultrastructural changes in experimentalmyocardial infarction, " Circulation, vol. 87, no. 3, pp. 909-920, 1993.
8. J. Banchereau, F. Briere, C. Caux et al., "Immunobiology of dendritic cells, " Annual Review of Immunology, vol. 18, pp. 767-811, 2000.
9. F. Sallusto, B. Palermo, D. Lenig et al., "Distinct patterns and kinetics of chemokine production regulate dendritic cell function, " European Journal of Immunology, vol. 29, no. 5, pp. 1617-1625, 1999.
10. C. Delgado-Martin, C. Escribano, J. L. Pablos, L. Riol-Blanco, and J. L. Rodriguez-Fernandez, "Chemokine CXCL12 uses CXCR4 and a signaling core formed by bifunctional akt, Extracellular Signal-regulated Kinase (ERK)1/2, and Mammalian Target of Rapamycin Complex 1 (mTORC1) proteins to control chemotaxis and survival simultaneously in mature dendritic cells, " The Journal of Biological Chemistry, vol. 286, no. 43, pp. 37222-37236, 2011.
11. G. J. Randolph, J. Ochando, and S. Partida-Sanchez, "Migration of dendritic cell subsets and their precursors, " Annual Review of Immunology, vol. 26, pp. 293-316, 2008.
12. J. M. Curtsinger and M. F. Mescher, "Inflammatory cytokines as a third signal for T cell activation, " Current Opinion in Immunology, vol. 22, no. 3, pp. 333-340, 2010.
13. J. Frostegard, "Immunity, atherosclerosis and cardiovascular disease, " BMC Medicine, vol. 11, article 117, 2013.
14. M. Weis, C. L. Schlichting, E. G. Engleman, and J. P. Cooke, "Endothelial determinants of dendritic cell adhesion and migration: new implications for vascular diseases, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 11, pp. 1817-1823, 2002.
15. G. K. Hansson, "Inflammation, atherosclerosis, and coronary artery disease, " The New England Journal of Medicine, vol. 352, no. 16, pp. 1626-1695, 2005.
16. J. Frostegard, A.-K. Ulfgren, P. Nyberg et al., "Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines, " Atherosclerosis, vol. 145, no. 1, pp. 33-43, 1999.
17. L. S. Deluca and J. L. Gommerman, "Fine-tuning of dendritic cell biology by theTNF superfamily, " Nature Reviews Immunology, vol. 12, no. 5, pp. 339-351, 2012.
18. C. J. J. Alderman, P. R. Bunyard, B. M. Chain, J. C. Foreman, D. S. Leake, and D. R. Katz, "Effects of oxidised low density lipoprotein on dendritic cells: a possible immunoregulatory component of the atherogenic micro-environment?" Cardiovascular Research, vol. 55, no. 4, pp. 806-819, 2002.
19. J. Ge, Q. Jia, C. Liang et al., "Advanced glycosylation end products might promote atherosclerosis through inducing the immune maturation of dendritic cells, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 10, pp. 2157-2163, 2005.
20. A. Aicher, C. Heeschen, M. Mohaupt, J. P. Cooke, A. M. Zeiher, and S. Dimmeler, "Nicotine strongly activates dendritic cellmediated adaptive immunity: potential role for progression of atherosclerotic lesions, " Circulation, vol. 107, no. 4, pp. 604-611, 2003.
21. H. Lu, D. Huang, K. Yao et al., "Insulin enhances dendritic cell maturation and scavenger receptor-mediated uptake of oxidised low-density lipoprotein, " Journal of Diabetes and Its Complications, vol. 29, no. 4, pp. 465-471, 2015.
22. W. Nie, H. Yan, S. Li, W. Zhu, F. Fan, and J. Zhu, "Angiotensin II promotes atherogenesis through upregulating the expression of connexin 43 in dendritic cells, " Cellular and Molecular Biology (Noisy-le-Grand), vol. 61, no. 3, pp. 96-101, 2015.
23. A. Yilmaz, M. Lochno, F. Traeg et al., "Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques, " Atherosclerosis, vol. 176, no. 1, pp. 101-110, 2004.
24. A. Niessner, K. Sato, E. L. Chaikof, I. Colmegna, J. J. Goronzy, and C. M. Weyand, "Pathogen-sensing plasmacytoid dendritic cells stimulate cytotoxic T-cell function in the atherosclerotic plaque through interferon-α, " Circulation, vol. 114, no. 23, pp. 2482-2489, 2006.
25. A. Niessner, M. S. Shin, O. Pryshchep, J. J. Goronzy, E. L. Chaikof, and C. M. Weyand, "Synergistic proinflammatory effects of the antiviral cytokine interferon-α and toll-like receptor 4 ligands in the atherosclerotic plaque, " Circulation, vol. 116, no. 18, pp. 2043-2052, 2007.
26. I. Rohm, Y. Atiskova, S. Drobnik et al., "Decreased regulatory T cells in vulnerable atherosclerotic lesions: imbalance between pro- and anti-inflammatory cells in atherosclerosis, " Mediators of Inflammation, vol. 2015, Article ID 364710, 13 pages, 2015.
27. E. A. Van Vre, J. M. Bosmans, I. Van Brussel et al., "Immunohistochemical characterisation of dendritic cells in human atherosclerotic lesions: possible pitfalls, " Pathology, vol. 43, no. 3, pp. 239-247, 2011.
28. C. Erbel, K. Sato, F. B. Meyer et al., "Functional profile of activated dendritic cells in unstable atherosclerotic plaque, " Basic Research in Cardiology, vol. 102, no. 2, pp. 123-132, 2007.
29. A. Yilmaz, J. Weber, I. Cicha et al., "Decrease in circulating myeloid dendritic cell precursors in coronary artery disease, " Journal of the American College of Cardiology, vol. 48, no. 1, pp. 70-80, 2006.
30. E. A. Van Vre, V. Y. Hoymans, H. Bult et al., "Decreased number of circulating plasmacytoid dendritic cells in patients with atherosclerotic coronary artery disease, " Coronary Artery Disease, vol. 17, no. 3, pp. 243-248, 2006.
31. A. Yilmaz, T. Schaller, I. Cicha et al., "Predictive value of the decrease in circulating dendritic cell precursors in stable coronary artery disease, " Clinical Science, vol. 116, no. 4, pp. 353-363, 2009.
32. E. A. Van Vre, I. Van Brussel, K. O. de Beeck et al., "Changes in blood dendritic cell counts in relation to type of coronary artery disease and brachial endothelial cell function, " Coronary Artery Disease, vol. 21, no. 2, pp. 87-96, 2010.
33. I. Van Brussel, E. A. Van Vre, G. R. Y. De Meyer, C. J. Vrints, J. M. Bosmans, and H. Bult, "Decreased numbers of peripheral blood dendritic cells in patients with coronary artery disease are associated with diminished plasma Flt3 ligand levels and impaired plasmacytoid dendritic cell function, " Clinical Science, vol. 120, no. 9, pp. 415-426, 2011.
34. A. Abbas, I. Gregersen, S. Holm et al., "Interleukin 23 levels are increased in carotid atherosclerosis: possible role for the interleukin 23/interleukin 17 axis, " Stroke, vol. 46, pp. 793-799, 2015.
35. S. M. Cherian, Y. V. Bobryshev, H. Liang et al., "Immunohistochemical and ultrastructural evidence that dendritic cells infiltrate stenotic aortocoronary saphenous vein bypass grafts, " Cardiovascular Surgery, vol. 9, no. 2, pp. 194-200, 2001.
36. B. H. Bulkley and G. M. Hutchins, "Accelerated atherosclerosis. A morphologic study of 97 saphenous vein coronary artery bypass grafts, " Circulation, vol. 55, no. 1, pp. 163-169, 1977.
37. L. Campeau, M. Enjalbert, J. Lesperance, C. Vaislic, C. M. Grondin, and M. G. Bourassa, "Atherosclerosis and late closure of aortocoronary saphenous vein grafts: sequential angiographic studies at 2 weeks, 1 year, 5 to 7 years, and 10 to 12 years after surgery, " Circulation, vol. 68, no. 3, part 2, pp. II1-II7, 1983.
38. J. Ozmen, Y. V. Bobryshev, and R. S. A. Lord, "CD40 costimulatory molecule expression by dendritic cells in primary atherosclerotic lesions in carotid arteries and in stenotic saphenous vein coronary artery grafts, " Cardiovascular Surgery, vol. 9, no. 4, pp. 329-333, 2001.
39. G. Wick, M. Romen, A. Amberger et al., "Atherosclerosis, autoimmunity, and vascular-associated lymphoid tissue, " The FASEB Journal, vol. 11, no. 13, pp. 1199-1207, 1997.
40. P. S. Yusuf, S. Hawken, S. Ounpuu et al., "Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study, " The Lancet, vol. 364, no. 9438, pp. 937-952, 2004.
41. D. N. Muller, E. Shagdarsuren, J.-K. Park et al., "Immunosuppressive treatment protects against angiotensin II-induced renal damage, " The American Journal of Pathology, vol. 161, no. 5, pp. 1679-1693, 2002.
42. C. Nataraj, M. I. Oliverio, R. B. Mannon et al., "Angiotensin II regulates cellular immune responses through a calcineurindependent pathway, " The Journal of Clinical Investigation, vol. 104, no. 12, pp. 1693-1701, 1999.
43. M. S. Madhur, H. E. Lob, L. A. McCann et al., "Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction, " Hypertension, vol. 55, no. 2, pp. 500-507, 2010.
44. S. D. Crowley, Y.-S. Song, E. E. Lin, R. Griffiths, H.-S. Kim, and P. Ruiz, "Lymphocyte responses exacerbate angiotensin IIdependent hypertension, " The American Journal of Physiology- Regulatory Integrative and Comparative Physiology, vol. 298, no. 4, pp. R1089-R1097, 2010.
45. T. J. Guzik, N. E. Hoch, K. A. Brown et al., "Role of the T cell in the genesis of angiotensin II-induced hypertension and vascular dysfunction, " Journal of ExperimentalMedicine, vol. 204, no. 10, pp. 2449-2460, 2007.
46. H. Nguyen, V. L. Chiasson, P. Chatterjee, S. E. Kopriva, K. J. Young, and B. M. Mitchell, "Interleukin-17 causes Rhokinase- mediated endothelial dysfunction and hypertension, " Cardiovascular Research, vol. 97, no. 4, pp. 696-704, 2013.
47. A. Kirabo, V. Fontana, A. P. C. de Faria et al., "DC isoketalmodified proteins activate T cells and promote hypertension, " The Journal of Clinical Investigation, vol. 124, no. 10, pp. 4642-4656, 2014.
48. S. Sagar, P. P. Liu, and L. T. Cooper Jr., "Myocarditis, "TheLancet, vol. 379, no. 9817, pp. 738-747, 2012.
49. G. K. Griffin and A. H. Lichtman, "Two sides to every proinflammatory coin: new insights into the role of dendritic cells in the regulation of T-cell driven autoimmune myocarditis, " Circulation, vol. 127, no. 23, pp. 2257-2260, 2013.
50. R. R. Marty and U. Eriksson, "Dendritic cells and autoimmune heart failure, " International Journal of Cardiology, vol. 112, no. 1, pp. 34-39, 2006.
51. N. R. Rose, "Infection, mimics, and autoimmune disease, " The Journal of Clinical Investigation, vol. 107, no. 8, pp. 943-944, 2001.
52. K. Bachmaier, N. Nikolaus, L. M. de la Maza, P. Sukumar, A. Hessel, and J. M. Penninger, "Chlamydia infections and heart disease linked through antigenic mimicry, " Science, vol. 283, no. 5406, pp. 1335-1339, 1999.
53. U. Hofmann and S. Frantz, "Role of lymphocytes in myocardial injury, healing, and remodeling after myocardial infarction, " Circulation Research, vol. 116, no. 2, pp. 354-367, 2015.
54. A. Anzai, T. Anzai, S. Nagai et al., "Regulatory role of dendritic cells in postinfarction healing and left ventricular remodeling, " Circulation, vol. 125, no. 10, pp. 1234-1245, 2012.
55. K. Naito, T. Anzai, Y. Sugano et al., "Differential effects of GMCSF andG-CSF on infiltration of dendritic cells during early left ventricular remodeling after myocardial infarction, " Journal of Immunology, vol. 181, no. 8, pp. 5691-5701, 2008.
56. U. Hofmann, N. Beyersdorf, J. Weirather et al., "Activation of CD4+ T lymphocytes improves wound healing and survival after experimental myocardial infarction in mice, " Circulation, vol. 125, no. 13, pp. 1652-1663, 2012.
57. H. Liu, W. Gao, J. Yuan et al., "Exosomes derived fromdendritic cells improve cardiac function via activation of CD4+ T lymphocytes after myocardial infarction, " Journal of Molecular and Cellular Cardiology, vol. 91, pp. 123-133, 2016.
58. T. Nagai, S. Honda, Y. Sugano et al., "Decreased myocardial dendritic cells is associated with impaired reparative fibrosis and development of cardiac rupture aftermyocardial infarction in humans, " Journal of the American Heart Association, vol. 3, Article ID e000839, 2014.
59. D. Kretzschmar, S. Betge, A. Windisch et al., "Recruitment of circulating dendritic cell precursors into the infarcted myocardium and pro-inflammatory response in acute myocardial infarction, " Clinical Science, vol. 123, no. 6, pp. 387-398, 2012.
60. S. Kofler, Z. Sisic, N. Shvets, P. Lohse, and M. Weis, "Expression of circulatory dendritic cells and regulatory T-cells in patients with different subsets of coronary artery disease, " Journal of Cardiovascular Pharmacology, vol. 57, no. 5, pp. 542-549, 2011.
61. J. Wen, Y. Wen, L. Zhiliang et al., "A decrease in the percentage of circulating mDC precursors in patients with coronary heart disease: a relation to the severity and extent of coronary artery lesions?" Heart and Vessels, vol. 28, no. 2, pp. 135-142, 2013.
62. T. Fukunaga, H. Soejima, A. Irie et al., "High ratio of myeloid dendritic cells to plasmacytoid dendritic cells in blood of patients with acute coronary syndrome, " Circulation Journal, vol. 73, no. 10, pp. 1914-1919, 2009.
63. T. Carvalheiro, I. Velada, A. Valado et al., "Phenotypic and functional alterations on inflammatory peripheral blood cells after acute myocardial infarction, " Journal of Cardiovascular Translational Research, vol. 5, no. 3, pp. 309-320, 2012.
64. D. Fukui, H. Yasukawa, Y. Sugi et al., "Transient reduction and activation of circulating dendritic cells in patients with acute myocardial infarction, " International Journal of Cardiology, vol. 160, no. 3, pp. 216-219, 2012.
65. U. Eriksson, R. Ricci, L. Hunziker et al., "Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity, " Nature Medicine, vol. 9, no. 12, pp. 1484-1490, 2003.
66. A. L. P. Caforio, M. Grazzini, J. M. Mann et al., "Identification of α- and β-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy, " Circulation, vol. 85, no. 5, pp. 1734-1742, 1992.
67. Z. Kaya, C. Leib, and H. A. Katus, "Autoantibodies in heart failure and cardiac dysfunction, " Circulation Research, vol. 110, no. 1, pp. 145-158, 2012.
68. F. Leuschner, J. Li, S. Goser et al., "Absence of auto-antibodies against cardiac troponin I predicts improvement of left ventricular function after acutemyocardial infarction, " EuropeanHeart Journal, vol. 29, no. 16, pp. 1949-1955, 2008.
69. V. Boivin-Jahns, A. Schlipp, S. Hartmann et al., "Antibodies to cardiac receptors, " Herz, vol. 37, no. 8, pp. 843-848, 2012.
70. M. Afanasyeva, D. Georgakopoulos, D. F. Belardi et al., "Quantitative analysis of myocardial inflammation by flow cytometry in murine autoimmune myocarditis: correlation with cardiac function, " The American Journal of Pathology, vol. 164, no. 3, pp. 807-815, 2004.
71. R. Pistulli, S. Konig, S. Drobnik et al., "Decrease in dendritic cells in endomyocardial biopsies of human dilated cardiomyopathy, " European Journal ofHeart Failure, vol. 15, no. 9, pp. 974-985, 2013.
72. P. Athanassopoulos, L. M. B. Vaessen, A. P. W. M. Maat, A. H. M. M. Balk, W. Weimar, and A. J. J. C. Bogers, "Peripheral blood dendritic cells in human end-stage heart failure and the early post-transplant period: evidence for systemicTh1immune responses, " European Journal of Cardio-Thoracic Surgery, vol. 25, no. 4, pp. 619-626, 2004.
73. P. Athanassopoulos, A. H. M. M. Balk, L. M. B. Vaessen et al., "Blood dendritic cell levels and phenotypic characteristics in relation to etiology of end-stage heart failure: implications for dilated cardiomyopathy, " International Journal ofCardiology, vol. 131, no. 2, pp. 246-256, 2009.
74. Y. Sugi, H. Yasukawa, H. Kai et al., "Reduction and activation of circulating dendritic cells in patients with decompensated heart failure, " International Journal of Cardiology, vol. 147, no. 2, pp. 258-264, 2011.
75. M. Dieterlen, F. W. Mohr, H. Reichenspurner, and M. J. Barten, "Clinical value of flow cytometric assessment of dendritic cell subsets in peripheral blood after solid organ transplantation, " Cytometry A, vol. 87, no. 5, pp. 377-379, 2015.
76. P. Athanassopoulos, L. M. B. Vaessen, A. H. M. M. Balk et al., "Impaired circulating dendritic cell reconstitution identifies rejecting recipients after clinical heart transplantation independent of rejection therapy, " European Journal of Cardio-Thoracic Surgery, vol. 27, no. 5, pp. 783-789, 2005.
77. P. Athanassopoulos, L. M. B. Vaessen, A. P. W. M. Maat et al., "Preferential depletion of blood myeloid dendritic cells during acute cardiac allograft rejection under controlled immunosuppression, " American Journal of Transplantation, vol. 5, no. 4, pp. 810-820, 2005.
78. C. S. K. Ho, J. A. Lopez, S. Vuckovic, C. M. Pyke, R. L. Hockey, and D. N. J. Hart, "Surgical and physical stress increases circulating blood dendritic cell counts independently of monocyte counts, " Blood, vol. 98, no. 1, pp. 140-145, 2001.
79. F. S. Dhabhar and B. S. McEwen, "Enhancing versus suppressive effects of stress hormones on skin immune function, " Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 3, pp. 1059-1064, 1999.
80. P. Monti, P. Allavena, V. Di Carlo, and L. Piemonti, "Effects of anti-lymphocytes and anti-thymocytes globulin on human dendritic cells, " International Immunopharmacology, vol. 3, no. 2, pp. 189-196, 2003.
81. T. Luft, M. Jefford, P. Luetjens et al., "Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E2 regulates the migratory capacity of specificDC subsets, " Blood, vol. 100, no. 4, pp. 1362-1372, 2002.
82. E. Scandella, Y. Men, D. F. Legler et al., "CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2, " Blood, vol. 103, no. 5, pp. 1595-1601, 2004.
83. G. J. Randolph, "Dendritic cell migration to lymph nodes: cytokines, chemokines, and lipid mediators, " Seminars in Immunology, vol. 13, no. 5, pp. 267-274, 2001.
84. G. Szabo, C. Gavala, and P. Mandrekar, "Tacrolimus and cyclosporine A inhibit allostimulatory capacity and cytokine production of human myeloid dendritic cells, " Journal of Investigative Medicine, vol. 49, no. 5, pp. 442-449, 2001.
85. P.-H. Chiang, L. Wang, C. A. Bonham et al., "Mechanistic insights into impaired dendritic cell function by rapamycin: inhibition of Jak2/Stat4 signaling pathway, " The Journal of Immunology, vol. 172, no. 3, pp. 1355-1363, 2004.
86. C. Lagaraine and Y. Lebranchu, "Effects of immunosuppressive drugs on dendritic cells and tolerance induction, " Transplantation, vol. 75, no. 9, pp. 37S-42S, 2003.
87. M. Moser, T. De Smedt, T. Sornasse et al., "Glucocorticoids down-regulate dendritic cell function in vitro and in vivo, " European Journal of Immunology, vol. 25, no. 10, pp. 2818-2824, 1995.
88. P. P. C. Boor, H. J. Metselaar, S. Mancham, H. W. Tilanus, J. G. Kusters, and J. Kwekkeboom, "Prednisolone suppresses the function and promotes apoptosis of plasmacytoid dendritic cells, " American Journal of Transplantation, vol. 6, no. 10, pp. 2332-2341, 2006.
89. M. Shodell and F. P. Siegal, "Corticosteroids depress IFN- α-producing plasmacytoid dendritic cells in human blood, " Journal of Allergy and Clinical Immunology, vol. 108, no. 3, pp. 446-448, 2001.
90. G. Raimondi and A. W. Thomson, "Dendritic cells, tolerance and therapy of organ allograft rejection, " Contributions to Nephrology, vol. 146, pp. 105-120, 2005.
91. M. Abe and A. W. Thomson, "Influence of immunosuppressive drugs on dendritic cells, " Transplant Immunology, vol. 11, no. 3-4, pp. 357-365, 2003.
92. K. L. Womer, R. Peng, P. R. Patton et al., "The effects of renal transplantation on peripheral blood dendritic cells, " Clinical Transplantation, vol. 19, no. 5, pp. 659-667, 2005.
93. V. Daniel, "Dendritic cells and immunosuppression after organ transplantation, " LaboratoriumsMedizin, vol. 32, no. 3, pp. 131-139, 2008.
94. K. John, M.-T. Dieterlen, A. Tarnok et al., "Roleofdendritic cells in the context of acute cellular rejection: comparison between tacrolimus- or cyclosporine A-treated heart transplanted recipients, " Cytometry B-Clinical Cytometry, vol. 86, no. 5, pp. 362-367, 2014.
95. M. J. Barten, J. Garbade, H. B. Bittner et al., "Affects of immuno suppression on circulating dendritic cells: an adjunct to therapeutic drug monitoring after heart transplantation, " International Immunopharmacology, vol. 6, no. 13-14, pp. 2011-2017, 2006.
96. C. van Kooten, G. Lombardi, K. A. Gelderman et al., "Dendritic cells as a tool to induce transplantation tolerance: obstacles and opportunities, " Transplantation, vol. 91, no. 1, pp. 2-7, 2011.
97. U. Svajger and P. Rozman, "Tolerogenic dendritic cells: molecular and cellular mechanisms in transplantation, " Journal of Leukocyte Biology, vol. 95, no. 1, pp. 53-69, 2014.
98. A. Moreau, E. Varey, L. Bouchet-Delbos, and M. C. Cuturi, "Cell therapy using tolerogenic dendritic cells in transplantation, " Transplantation Research, vol. 1, no. 1, article 13, 2012.
99. A. Lamioni, F. Parisi, G. Isacchi et al., "The immunological effects of extracorporeal photopheresis unraveled: induction of tolerogenic dendritic cells in vitro and regulatory T cells in vivo, " Transplantation, vol. 79, no. 7, pp. 846-850, 2005.
100. M.-T. Dieterlen, H. B. Bittner, A. Pierzchalski, S. Dhein, F. W. Mohr, and M. J. Barten, "Immunological monitoring of extracorporeal photopheresis after heart transplantation, " Clinical and Experimental Immunology, vol. 176, no. 1, pp. 120-128, 2014.
101. M. Abe, Z. Wang, A. de Creus, and A. W. Thomson, "Plasmacytoid dendritic cell precursors induce allogeneic T-cell hyporesponsiveness and prolong heart graft survival, "American Journal of Transplantation, vol. 5, no. 8, pp. 1808-1819, 2005.
102. P. Bjorck, P. T. H. Coates, Z. Wang, F. J. Duncan, and A. W. Thomson, "Promotion of long-term heart allograft survival by combination of mobilized donor plasmacytoid dendritic cells and anti-CD154 monoclonal antibody, " Journal of Heart and Lung Transplantation, vol. 24, no. 8, pp. 1118-1120, 2005.
103. H. Li and B. Shi, "Tolerogenic dendritic cells and their applications in transplantation, " Cellular and Molecular Immunology, vol. 12, no. 1, pp. 24-30, 2015.
104. S. Gregori, D. Tomasoni, V. Pacciani et al., "Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway, " Blood, vol. 116, no. 6, pp. 935-944, 2010.
105. L. J. Young, N. S. Wilson, P. Schnorrer et al., "Differential MHC class II synthesis and ubiquitination confers distinct antigenpresenting properties on conventional and plasmacytoid dendritic cells, " Nature Immunology, vol. 9, no. 11, pp. 1244-1252, 2008.
106. O. H. Gerstner, W. Laffers, and A. Tarnok, "Clinical applications of slide-based cytometry-an update, " Journal of Biophotonics, vol. 2, no. 8-9, pp. 463-469, 2009.
107. S. M. Cherian, Y. V. Bobryshev, S. J. Inder, A. Y. Wang, R. S. A. Lord, and A. E. Farnsworth, "Dendritic cells in aortocoronary saphenous vein bypass grafts, " Heart Lung and Circulation, vol. 9, no. 1, pp. 39-42, 2000.